RAGE Signaling in Melanoma Tumors

Despite recent progresses in its treatment, malignant cutaneous<b> </b>melanoma remains a cancer with very poor prognosis. Emerging evidences suggest that the receptor for advance glycation end products (RAGE) plays a key role in melanoma progression through its activation in both cancer...

Full description

Bibliographic Details
Main Authors: Olamide T. Olaoba, Sultan Kadasah, Stefan W. Vetter, Estelle Leclerc
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/21/23/8989